Eli Lilly, the maker of tirzepatide, recently published results of a head-to-head trial comparing weight loss of Zepbound (tirzepatide) and Wegovy (semaglutide)
In May, VCU researchers published a study in the journal JAMA Network Open that suggested that breast-cancer patients who used GLP-1s had better outcomes than those who didnt
It's worth being precise about the mechanism the brand is describing, because "GLP-1 booster" can sound like it means the same thing as a prescription GLP-1 drug, and it doesn't
Staying hydrated and engaging in regular physical activity are other practical steps that help manage bloating
Quick Answer: Generalized skin sensitivity is not a recognized adverse effect in FDA labeling for semaglutide, though injection site reactions occur in 1.4-2.4% of patients using subcutaneous formulations
The gradual withdrawal approach also minimizes rebound hunger and gives you time to strengthen the dietary and exercise habits you've built during treatment